Tet inhibits Wnt/β-catenin pathway activity and reduces metastatic tumor antigen 1 (MTA1) expression, preventing metastasis in human hepatocellular carcinoma (HCC) (Zhang et al., 2018). This evidence concerns the gene MTA1 and hepatocellular carcinoma.